BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34685704)

  • 1. The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells.
    Ortiz-Hernandez GL; Sanchez-Hernandez ES; Ochoa PT; Elix CC; Alkashgari HR; McMullen JRW; Soto U; Martinez SR; Diaz Osterman CJ; Mahler M; Roy S; Casiano CA
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells.
    Sanchez-Hernandez ES; Ochoa PT; Suzuki T; Ortiz-Hernandez GL; Unternaehrer JJ; Alkashgari HR; Diaz Osterman CJ; Martinez SR; Chen Z; Kremsky I; Wang C; Casiano CA
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of the ternary complex formed by c-Myc interactor JPO2, transcriptional co-activator LEDGF/p75, and chromatin.
    Hendrix J; van Heertum B; Vanstreels E; Daelemans D; De Rijck J
    J Biol Chem; 2014 May; 289(18):12494-506. PubMed ID: 24634210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75.
    Bartholomeeusen K; De Rijck J; Busschots K; Desender L; Gijsbers R; Emiliani S; Benarous R; Debyser Z; Christ F
    J Mol Biol; 2007 Sep; 372(2):407-21. PubMed ID: 17669426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif.
    Tesina P; Čermáková K; Hořejší M; Procházková K; Fábry M; Sharma S; Christ F; Demeulemeester J; Debyser Z; Rijck J; Veverka V; Řezáčová P
    Nat Commun; 2015 Aug; 6():7968. PubMed ID: 26245978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.
    Zhang L; Jiao M; Li L; Wu D; Wu K; Li X; Zhu G; Dang Q; Wang X; Hsieh JT; He D
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):675-86. PubMed ID: 22237455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.
    Basu A; Cajigas-Du Ross CK; Rios-Colon L; Mediavilla-Varela M; Daniels-Wells TR; Leoh LS; Rojas H; Banerjee H; Martinez SR; Acevedo-Martinez S; Casiano CA
    PLoS One; 2016; 11(1):e0146549. PubMed ID: 26771192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.
    Mediavilla-Varela M; Pacheco FJ; Almaguel F; Perez J; Sahakian E; Daniels TR; Leoh LS; Padilla A; Wall NR; Lilly MB; De Leon M; Casiano CA
    Mol Cancer; 2009 Aug; 8():68. PubMed ID: 19715609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia.
    Cermáková K; Tesina P; Demeulemeester J; El Ashkar S; Méreau H; Schwaller J; Rezáčová P; Veverka V; De Rijck J
    Cancer Res; 2014 Sep; 74(18):5139-51. PubMed ID: 25082813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering.
    Vanegas M; Llano M; Delgado S; Thompson D; Peretz M; Poeschla E
    J Cell Sci; 2005 Apr; 118(Pt 8):1733-43. PubMed ID: 15797927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.
    Ríos-Colón L; Cajigas-Du Ross CK; Basu A; Elix C; Alicea-Polanco I; Sanchez TW; Radhakrishnan V; Chen CS; Casiano CA
    Oncotarget; 2017 Apr; 8(15):24915-24931. PubMed ID: 28212536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stress oncoprotein LEDGF/p75 interacts with the methyl CpG binding protein MeCP2 and influences its transcriptional activity.
    Leoh LS; van Heertum B; De Rijck J; Filippova M; Rios-Colon L; Basu A; Martinez SR; Tungteakkhun SS; Filippov V; Christ F; De Leon M; Debyser Z; Casiano CA
    Mol Cancer Res; 2012 Mar; 10(3):378-91. PubMed ID: 22275515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells.
    Maertens G; Cherepanov P; Pluymers W; Busschots K; De Clercq E; Debyser Z; Engelborghs Y
    J Biol Chem; 2003 Aug; 278(35):33528-39. PubMed ID: 12796494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase.
    Cherepanov P; Devroe E; Silver PA; Engelman A
    J Biol Chem; 2004 Nov; 279(47):48883-92. PubMed ID: 15371438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation.
    Sharma S; Čermáková K; De Rijck J; Demeulemeester J; Fábry M; El Ashkar S; Van Belle S; Lepšík M; Tesina P; Duchoslav V; Novák P; Hubálek M; Srb P; Christ F; Řezáčová P; Hodges HC; Debyser Z; Veverka V
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7053-E7062. PubMed ID: 29997176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75.
    Llano M; Vanegas M; Hutchins N; Thompson D; Delgado S; Poeschla EM
    J Mol Biol; 2006 Jul; 360(4):760-73. PubMed ID: 16793062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis.
    Daniels T; Zhang J; Gutierrez I; Elliot ML; Yamada B; Heeb MJ; Sheets SM; Wu X; Casiano CA
    Prostate; 2005 Jan; 62(1):14-26. PubMed ID: 15389814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor.
    Wang H; Jurado KA; Wu X; Shun MC; Li X; Ferris AL; Smith SJ; Patel PA; Fuchs JR; Cherepanov P; Kvaratskhelia M; Hughes SH; Engelman A
    Nucleic Acids Res; 2012 Dec; 40(22):11518-30. PubMed ID: 23042676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lens epithelium-derived growth factor/p75 interacts with the transposase-derived DDE domain of PogZ.
    Bartholomeeusen K; Christ F; Hendrix J; Rain JC; Emiliani S; Benarous R; Debyser Z; Gijsbers R; De Rijck J
    J Biol Chem; 2009 Apr; 284(17):11467-77. PubMed ID: 19244240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanism of LEDGF/p75 Dimerization.
    Lux V; Brouns T; Čermáková K; Srb P; Fábry M; Mádlíková M; Hořejší M; Kukačka Z; Novák P; Kugler M; Brynda J; DeRijck J; Christ F; Debyser Z; Veverka V
    Structure; 2020 Dec; 28(12):1288-1299.e7. PubMed ID: 32946742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.